Activated (p)STAT1 and (p)STAT3 have often been assigned a role as oncogenic factors, including in melanoma [26, 27] whereas in prostate, lung and colorectal carcinomas, tumor suppressive roles were associated with STAT3 function depending on the mutational context [28–31]. This evidence concerns the gene STAT3 and melanoma.